uPMR Zenith
Shanghai United Imaging Healthcare Co., Ltd. · Decision date Oct 28, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the uPMR Zenith, a tomographic imager combining emission computed tomography with nuclear magnetic resonance, under 510(k) number K261676. The applicant is Shanghai United Imaging Healthcare Co., Ltd. of Shanghai, China. The decision date is 2026-10-28, with the application received 05/21/2026. The submission is a Traditional 510(k) in the Radiology specialty and review panel, classified under product code OUO with subsequent product code MOS and regulation number 892.1200.
SESE in this 510(k) context means the device was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The record shows the review was not conducted by a third party, the product was not a combination product, and no Predetermined Change Control Plan was authorized. The public record does not state the predicate device, the specific components or changes assessed, or any clinical performance data, so those details remain unknown from this source.
The listed device classification name describes a combined emission computed tomography and nuclear magnetic resonance imager, but the record does not specify the device's indications, patient-selection criteria, imaging protocols or labeling. Those elements would need to be read from the linked FDA summary document rather than inferred here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 28, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261676
- Regulatory pathway
- 510(k) premarket notification
- Product code
- OUO
- Decision code
- SESE
- Decision date
- Oct 28, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tomographic Imager Combining Emission Computed Tomography With Nuclear Magnetic Resonance.
- Product code
- OUO
- FDA device class
- 2
FDA decision timeline
K261676 received
Application receipt date recorded by FDA.
K261676 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shanghai United Imaging Healthcare Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shanghai
Sources and methodology
- Original FDA record: K261676
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records